To investigate patient's outcome using different hemofilter materials in those with sepsis associated acute renal failure
Not Applicable
Terminated
- Conditions
- Severe sepsisAcute kidney injuryRenal and Urogenital - Kidney diseaseInfection - Other infectious diseases
- Registration Number
- ACTRN12611000652976
- Lead Sponsor
- Department of intensive care, Pamela Youde Nethersole Eastern Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1.Severe sepsis (defined based on ACCP/ SCCM criteria, ie Systemic Inflammatory Response Syndrome in the presence of suspected or known infection, leading to organ dysfunction), and
2.Acute kidney injury (defined based on RIFLE criteria, Injury” grade or above, who required continuous venovenous hemofiltration support)
Exclusion Criteria
1.Contraindication for regional citrate anticoagulation (Liver failure or cirrhosis with impaired citrate metabolism, allergy to citrate)
2.Pregnancy
3.Terminal illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality[28 days]
- Secondary Outcome Measures
Name Time Method ength of stay in hospital[Hospital discharge time];Sequential Organ Failure Assessment (SOFA) score[Daily until death or discharge from ICU];Best mean arterial pressure (MAP)[Daily until death or discharge from ICU];Vasopressor dosage[Daily until death or discharge from ICU];Best Oxygenation (PaO2/FiO2 ratio) based on arterial blood gas results and oxygen concentration provided via oxygen cannula or ventilator[Daily until death or discharge from ICU];Urine output based on all urinary catheter output charting[Daily until death or discharge from ICU];Length of stay in intensive care unit (ICU)[ICU discharge time]